PCCvalethealth2023-09-29T18:52:44+00:00

Congratulations!

Based on your survey responses, you MAY qualify for the PearlPAK™ treatment, a solution to help you through your journey of menopause.

What to expect next:

Once you click to connect with the telehealth medical practitioner, your payment information will be collected.

NO charges to your credit/debit card will be made until AFTER your appointment and commitment to a prescription.

Conversation with our patient care Registered Nurse.

Clarify your responses to questionnaire and explore if the PearlPAK™ treatment is appropriate for you, and forward your information to the telehealth medical practitioner if deemed appropriate.

Connection with a board-certified telehealth medical practitioner.

Confirm your responses to questionnaire and explore if the PearlPAK™ treatment is appropriate for you.

Prescription written if you and the medical practitioner agree.

Compounding pharmacy will fill and send your prescription directly to your door.

Continue to Registered Nurse Appointment

PearlPak Box1

When you receive your package:

Your CleopatraRX package will include three 28-day cycles of your PearlPAK treatment system.

Each 28-day cycle consists of a tailored prescription combination for weeks 1 & 2, and a prescription combination for weeks 3 & 4.

Your Prescription:

Weeks 1 & 2 Include:

A specified dose of estriol to be taken in the morning.
An evening dose of either a placebo or progesterone.

Weeks 3 & 4 Include:

A specified dose of estriol to be taken in the morning.
An evening dose of either a progesterone or placebo

PearlPak Boxes1

© Copyright 2023 CleopatraRX™. All Rights Reserved. View our Privacy Policy.

*PearlPAK™️ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and is used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product for use as a drug/routine system and/or treatment.

The PearlPAK™️ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post-menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.

*PearlPAK™ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product is for use as a drug/routine system and/or treatment.

The PearlPAK™ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post – menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.